A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.32, Iss.3, 2012-03, pp. : 179-187

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessing the Value of a Future Study

By Gandjour Afschin

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 891-892

Adis International

Access to resources Recommend Favorite

Biomarkers of Aging with Prognostic and Predictive Value in Non-Oncological Diseases

Current Medicinal Chemistry, Vol. 16, Iss. 27, 2009-09 ,pp. : 3469-3475

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Value of Biomarkers in Patients with Heart Failure

Current Medicinal Chemistry, Vol. 19, Iss. 16, 2012-06 ,pp. : 2534-2547

Bentham Science Publishers

Access to resources Recommend Favorite

Should patients with severe sepsis receive drotrecogin alfa?

Inpharma, Vol. 1, Iss. 1508, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Safety of drotrecogin alfa (activated) in the treatment of patients with severe sepsis

By McCoy Christopher

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 625-637

Informa Healthcare

Access to resources Recommend Favorite